U.S. FDA issues 4 observations for Dr. Reddy’s API unit in Srikakulam
Dr Reddy's manufacturing unit in Andhra Pradesh gets 4 observations from US FDA
By Jomy Pullokaran
USFDA issues Form 483 with four observations to Dr Reddy's API unit
Dr Reddy's Labs gets 4 USFDA observations for Srikakulam facility
By Ruchika Sharma and Kamal Kohli
Full coverage of this story
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
GSK exec lauds 'great start' to RSV vaccine uptake as Arexvy nabs label expansion in adults 50-59
By Fraiser Kansteiner
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
US gets 3rd vaccine against highly contagious Respiratory virus RSV. How India can benefit from these
By Sumi Dutta
Moderna's RSV shot wins FDA approval for use in older adults
Full coverage of this story
FDA Advises Tougher Raw Milk Rules as Bird Flu Spreads in Dairy Herds
Full coverage of this story
Biocon Biologics announces getting US FDA approval for eye treatment drug
By Aneeka Chatterjee
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market
US FDA approves two biosimilars for blockbuster eye drug Eylea
By Sriparna Roy, Leroy Leo and Anil Dsilva
USFDA approves Biocon Biologics' biosimilar product to treat ophthalmology conditions
FDA Roundup: Eylea Biosimilars, Belimumab Autoinjector
By Killian Meara
Full coverage of this story
Zydus Lifesciences shares slip 4% as USFDA issues 10 observations for Gujarat unit
By Aseem Thapliyal
Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat
By Sumi Dutta
9 States Included in FDA Soda Recall: Here's What to Know
By Lauren Wellbank
The 28 sodas, juices and other drinks recalled by the FDA over harmful chemicals revealed
By Alexandra Klausner
Four popular sodas recalled by FDA for cancer-causing food dye
By Caitlin Tilley
Company recalls beverages over undeclared dyes, preservatives on labels
By Daniella Alessandra Genovese
Soft Drinks Recall Map Shows Nine States Impacted by Health Warning
By Jordan King
Full coverage of this story
Cipla rallies 4% on US FDA approval to market Lanreotide injection
Full coverage of this story
ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)
ChromaDex secures FDA orphan drug status for AT treatment By Investing.com
ChromaDex Shares Up on Regulatory Designations for Neurological Disorder Treatment
By Adriano Marchese
ChromaDex wins orphan designation for rare ataxia drug
By Justine Ra
ChromaDex Corp rises on orphan drug tag to develop treatment for genetic disease
Full coverage of this story
FDA AdCom to question efficacy and safety concerns with Eli Lilly's Alzheimer's drug
By Abigail Beaney
At long last, Geron wins FDA approval of first drug
By Paul Bonanos
Full coverage of this story
DePuy bags FDA 510(K) clarence for robotic-assisted knee surgery device
By Joshua Silverwood
Full coverage of this story
US FDA approves Basilea Pharmaceutica's antibiotic
By Sriparna Roy
US FDA approves first drug for fatty liver disease NASH
By Mariam E Sunny and Leroy Leo
US FDA chief very concerned about fake weight loss drugs
By Caroline Humer
Soquelitinib Receives FDA Orphan Drug Designation FDA for T-Cell Lymphoma
By Courtney Flaherty
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
By Jen Christensen
Full coverage of this story